Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling for tissue regeneration refers to the process by which cells (including stem cells, immune cells, and others) release signaling molecules—such as growth factors (e.g., VEGF, FGF, PDGF), cytokines, chemokines, and extracellular vesicles (like exosomes)—to influence the behavior of neighboring cells after tissue injury. This mechanism is crucial for orchestrating complex repair processes such as angiogenesis (blood vessel growth), modulation of immune responses, and stimulation of cell proliferation and differentiation necessary for tissue repair and regeneration. Paracrine signaling is an essential component in regenerative medicine and stem cell therapies, with potential therapeutic applications for a wide range of degenerative and injury-related diseases, though it is not itself a druggable target in the traditional sense[1][2][3][4][5][6][7][8][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling for tissue regeneration.